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LEUERS TO THE EDITOR
Macrophage migration
inhibitory factor in IgA
nephropathy
To the Editor' Macrophage migration inhibitory factor
(MIF) was the first lymphokine identified in activated
T-lymphocytes that induced pro inflammatory cytokines,
such as interleukin-1 and tumor necrosis factor-a. Re-
cently, it was reported that MIF expression may play an
important role in macrophage accumulation and progres-
sive renal injury in crescentic glomerulonephritis in rats [1].
To investigate the role of MIF in human IgA nephrop-
athy, we examined 20 patients (11 men and 9 women aged
18 to 52 years; mean si; 32.7 11.9) who underwent
renal biopsy at the Second Department of Internal Medi-
cine of Hiroshima University School of Medicine. The
diagnosis of IgA nephropathy was based on clinical, )ight
microscopic, electron microscopic, and inimun ofluores-
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cence findings. Kidney tissue fixed in formalin and embed-
ded in paraffin was used to localize MIF. The sections were
deparaffinized using xylene and alcohol, and the antigen
was unmasked in 0.01% trypsin diluted with 0.06 M PBS
(p1-I 7.2) for 30 minutes at 37°C. Then the sections were
incubated overnight at 4°C in a moist chamber with the
primary antibody (monoclonal anti-human MIF antibody;
R & D Systems Inc, Minneapolis, MN, USA). After
washing with PBS (pH 7.6) for 30 minutes, the sections
were reacted with rat EgG using an aviddin-biotin-peroxi-
dase complex kit (Vector Laboratories Inc., Burlingame,
CA, USA). Immunoproducts were visualized by app'ying
3,3 '-diaminobenzidine tetrahydrochioride (DAB).
The relationship between detection of MIF in the gb-
mcruli and the following clinical and histological parame-
ters was evaluated: total daily urinary protein excretion
(TUP), serum creatinine (SCr)' creatinine clearance (Cr),
and the detection of cellular crescents by renal biopsy.
MIF was localized mainly in the tubular epithelial cells
and proliferative mesangial lesions (Fig. 1). MW was
positive in the glomeruli of 6 of 20 patients (30%).
The average TUP level in patients positive for MIF was
1.9 0.5 g/day and it was 0.8 0.2 g/day in patients
negative for MW. TUP was significantly higher in patients
positive for MIF compared to patients who were negative
for MIF (P < 0.05). The median proportion of cellular
crescents was 15.3 3.3% in patients positive for MIF and
3.2 1.7% in patients negative for MIF, showing a
significant difference (P <0.01).
Fig. L. Light micrograph of immunohLstochemical staining for macrophage migration Inhibitory factor (MIF) in tissue from a patient with IgA
nepbropathy. There is segmenialstaining of the glomerular mesangium by the anti-MIF monoclonal antibody.
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gial cell response to injury, leading to increased mesangial
cell proliferation and glomerulosclerosis [2, 3]. Recently,
some investigators have reported that proliferating mesan-
gial cells express MIF, which may be involved in glomerular
macrophage accumulation in anti-Thy-I nephritis or anti-
GBM glomerulonephritis [4, 5). In this study, we demon-
strated that the presence of MIF in the glomeruli was
associated with clinical and histological parameters such as
TUP and the incidence of cellular crescents in patients with
IgA nephropathy. Therefore, MIF in the glomeruli may be
involved in crescent formation and in the clinical activity of
igA nephropathy.
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Th re was no relationship between positivity for MIF
and SC. or C levels. In human IgA nephropathy, infiltrat-
ing macrophage express infla matory cytokines such as
int rleukin-6, tumor necrosis factor, and platelet-derived
gial cell response to injury, leading to increased mesangial
cell proliferation and glomerulosclerosis [2, 3]. R cently,
some investigators hav  reported that proliferating mesan-
gial cells express MIF, which may be involved in glomerular
macrophage accumulatio  in anti-Thy-I nephritis or anti-
GBM glomerulonephritis [4, 5). In this study, we demon-
strated that the pr sence of MIF in the glomeruli was
associated with clinic l and histological parameters such as
TUP and the incidence of cellula  crescents in patients with
IgA nephropathy. Therefore, MIF in the glomeruli may be
involved in crescent formation and in the clinic l activity of
igA nephropathy.
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